SLC5A1 and non-small cell lung carcinoma: In contrast, overexpression of SGLT1 attenuated cetuximab-induced cell death (Fig. 6i and Supplementary Fig. S7h), PARP and caspase 3 cleavage, and AMPK activation (Fig. 6j) in parental NSCLC cells.